Chinese Journal of Tissue Engineering Research ›› 2011, Vol. 15 ›› Issue (21): 3834-3838.doi: 10.3969/j.issn.1673-8225.2011.21.008

Previous Articles     Next Articles

Cell biocompatibility of a new-type nanofiber scaffold for tissue engineering

Cao Xi-ying1, Weng Guo-xing1, Xiao Rong-dong1, Liu Hai-qing2, Wang Jiang-nan2   

  1. 1Department of Cardiovascular Surgery, Fujian Provincial Hospital, Clinical Medical College, Fujian Medical University, Fuzhou  350001, Fujian Province, China
    2College of Chemistry and Materials Science, Fujian Normal University, Key Laboratory of Polymer Materials of Fujian Province, Fuzhou  350007, Fujian Province, China
  • Received:2010-11-05 Revised:2011-03-23 Online:2011-05-21 Published:2011-05-21
  • Contact: Weng Guo-xing, Master, Professor, Depatment of Cardiovascular Surgery, Fujian Provincial Hospital, Clinical Medical College, Fujian Medical University, Fuzhou 350001, Fujian Province, China gxw001@sina.com
  • About author:Cao Xi-ying★, Studying for master’s degree, Depatment of Cardiovascular Surgery, Fujian Provincial Hospital, Clinical Medical College, Fujian Medical University, Fuzhou 350001, Fujian Province, China xiyingcao@163.com

Abstract:

BACKGROUND: High-porosity polycaprolactone (PCL) nanofiber scaffolds have a good multi-pore structure for the adhesion and proliferation of vascular smooth muscle cells and perfect biocompatibility.
OBJECTIVE: To evaluate the cell biocompatibility of high-porosity PCL scaffold made by electrostatic spinning technology.
METHODS: Electrostatic spinning technology was used to produce high-porosity PCL nanofiber stents. WST-1 method was used to evaluate the effects of scaffold on the adhesion and proliferation of smooth muscle cells cultured with different scaffolds. Light microscope and scanning electron microscope were used to observe the morphology of cells.
RESULTS AND CONCLUSION: The high-porosity PCL scaffold exhibited better biocompatibility than the traditional one in cell morphology, adhesion and proliferation. It is indicated that the high-porosity PCL nanofiber stents produced by electrostatic spinning technology owns better biocompatibility.

CLC Number: